Login

Healthcare

00:00:00
Update from Genesis HealthCare System CEO & President Matthew J. Perry
00:00:00
ImmuPharma CEO Tim McCarthy discusses financial stability and promising drug developments -Tim McCarthy, FCCA, MBA - Chief Executive Officer, ImmuPharma
00:00:00
ImmuPharma "absolutely delighted" to push on with new clinical trial -Tim McCarthy, FCCA, MBA - Chief Executive Officer, ImmuPharma
00:00:00
Immunicum | CEO interview, Erik Manting, CEO, Immunicum
00:00:00
CEO Paul McDonald talks of the huge pipeline going forward - Paul McDonald Chief Executive Officer, IDT Australia Ltd
00:00:00
Futura Medical "on track for a profit in 2025" after strong first half - James Barder, Chief Executive, Futura Medical
00:00:00
Futura Medical continues global expansion with Latin America announcement - James Barder, Chief Executive, Futura Medical
00:00:00
Faron Pharmaceuticals kicks off second half with FDA announcement -Dr. Markku Jalkanen, CEO, Faron Pharmaceuticals
00:00:00
Faron Pharmaceuticals initiates second phase of BEXMAB study -Dr. Markku Jalkanen, CEO, Faron Pharmaceuticals
00:00:00
Faron Pharmaceuticals CEO delighted with latest BEXMAB study findings - Dr. Markku Jalkanen, CEO, Faron Pharmaceuticals
00:00:00
Faron Pharmaceuticals Oy excited by green light for trials of promising anti-cancer treatment - Dr. Markku Jalkanen, CEO, Faron Pharmaceuticals
00:00:00
Dr. Markku Jalkanen, CEO, Faron Pharmaceuticals
00:00:00
From the operating room to the C-suite in pharma - Jay S. Duker, MD President & CEO and Board Director, Eyepoint Pharmaceuticals Inc
00:00:00
EyeGate Pharma Moving Fast Toward Commercialization - Stephen From , CEO, EyeGate Pharmaceuticals Inc
00:00:00
Executive interview – Dr Heikki Lanckriet, CEO, Expedeon
00:00:00
Evgen Pharma talks through clinical milestones and financial results from its 2022 full year report - Huw Jones, CEO, Evgen Pharma

© 2026 Nehu